Laurus Investment Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRC Health Common Stock
NRC
|
+$987K |
| 2 |
Chemed
CHE
|
+$969K |
| 3 |
Winmark
WINA
|
+$557K |
| 4 |
Five Below
FIVE
|
+$177K |
| 5 |
Exponent
EXPO
|
+$138K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SBNY
Signature Bank
SBNY
|
+$14.7M |
| 2 |
Hingham Institution for Saving
HIFS
|
+$2.1M |
| 3 |
SMLR
Semler Scientific
SMLR
|
+$582K |
| 4 |
CIXX
CI Financial Corp.
CIXX
|
+$203K |
| 5 |
S&P Global
SPGI
|
+$134K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.51% |
| 2 | Healthcare | 19.33% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 8.66% |
| 5 | Communication Services | 8.63% |
Similar funds
Laurus Investment Counsel's Q1 2023 Portfolio in Review
As of Q1 2023, Laurus Investment Counsel held 50 positions worth $280M, up 4.1% from $269M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Laurus Investment Counsel withdrew a net $14.5M in Q1 2023, closing 10 positions and reducing 6 holdings. Its most notable exit was Signature Bank, an estimated $14.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 41% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Laurus Investment Counsel opened a new position in NRC Health Common Stock worth $1.32M.
- Laurus Investment Counsel's largest Q1 2023 buy was NRC Health Common Stock: 22,350 shares worth $1.32M.
- Laurus Investment Counsel added most to Chemed in Q1 2023, an estimated $969K increase.
- Laurus Investment Counsel's biggest Q1 2023 reduction was S&P Global, cutting an estimated $134K.
- Laurus Investment Counsel fully exited Signature Bank in Q1 2023, selling an estimated $14.7M.
- Laurus Investment Counsel's ten largest holdings make up 64% of its $280M portfolio in Q1 2023.
- Laurus Investment Counsel opened 1 new position and closed 10 in Q1 2023.
- Laurus Investment Counsel's portfolio value rose 4.1% quarter-over-quarter to $280M.
Based on Laurus Investment Counsel's 13F filing for Q1 2023, filed 13 Apr 2023.